ID   NCC-CCS1-X4-C1
AC   CVCL_B3TR
SY   NCCCCS1X4C1
DR   DepMap; ACH-002793
DR   Wikidata; Q110433080
RX   PubMed=29197033;
WW   https://en.cellline.jp/product/ncc-ccs1-x4-c1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a fourth generation xenograft established by subcutaneous injection in female NOD/Shi-scid IL-2Rgammanull mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 17 hours (PubMed=29197033).
CC   Sequence variation: Gene fusion; HGNC; 783; ATF1 + HGNC; 3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF (PubMed=29197033).
CC   Omics: Deep proteome analysis.
CC   Derived from site: Metastatic; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): PubMed=29197033
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 11
ST   D21S11: 30,31
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TS ! NCC-CCS1B-C1
OI   CVCL_B3TT ! NCC-CCS1B-X2-C1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 30-01-24; Version: 5
//
RX   PubMed=29197033; DOI=10.1007/s11626-017-0207-5;
RA   Sakumoto M., Oyama R., Takahashi M., Takai Y., Kito F., Shiozawa K.,
RA   Qiao Z.-W., Endo M., Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and proteomic characterization of patient-derived clear
RT   cell sarcoma xenografts and cell lines.";
RL   In Vitro Cell. Dev. Biol. Anim. 54:163-176(2018).
//